1.
Age of First Walking and Associations with Symptom Severity in Children with Suspected or Diagnosed Autism Spectrum Disorder
by Reindal, Lise
Journal of autism and developmental disorders, 2019-07-05, Vol.50 (9), p.3216-3232
2.
White matter microstructure in schizophrenia patients with a history of violence
by Tesli, Natalia
European archives of psychiatry and clinical neuroscience, 2019-01-29, Vol.271 (4), p.623-634
3.
Linkage-Disequilibrium-Based Binning Affects the Interpretation of GWASs
by Christoforou, Andrea
American journal of human genetics, 2012-04-06, Vol.90 (4), p.727-733
4.
Association between serum lipid levels, osteoprotegerin and depressive symptomatology in psychotic disorders
by Gohar, Sherif M
European archives of psychiatry and clinical neuroscience, 2018-05-02, Vol.269 (7), p.795-802
5.
Identifying Common Genetic Variants in Blood Pressure Due to Polygenic Pleiotropy With Associated Phenotypes
by Andreassen, Ole A
Hypertension (Dallas, Tex. 1979), 2014-04, Vol.63 (4), p.819-826
6.
A randomized controlled trial of training of affect recognition (TAR) in schizophrenia shows lasting effects for theory of mind
by Vaskinn, Anja
European archives of psychiatry and clinical neuroscience, 2019-03-02, Vol.269 (5), p.611-620
7.
Improvement in verbal learning over the first year of antipsychotic treatment is associated with serum HDL levels in a cohort of first episode psychosis patients
by Gjerde, Priyanthi B
European archives of psychiatry and clinical neuroscience, 2019-04-27, Vol.270 (1), p.49-58
8.
Excessive cannabis use is associated with earlier age at onset in bipolar disorder
by Lagerberg, Trine V
European archives of psychiatry and clinical neuroscience, 2011-01-26, Vol.261 (6), p.397-405
9.
d-amino acid oxidase activator gene (DAOA) variation affects cerebrospinal fluid homovanillic acid concentrations in healthy Caucasians
by Andreou, Dimitrios
European archives of psychiatry and clinical neuroscience, 2012-03-28, Vol.262 (7), p.549-556
10.
An Attempt to Identify Single Nucleotide Polymorphisms Contributing to Possible Relationships between Personality Traits and Oxytocin-Related Genes
by Haram, Marit
Neuropsychobiology, 2014-02, Vol.69 (1), p.25-30
11.
Improved Detection of Common Variants Associated with Schizophrenia by Leveraging Pleiotropy with Cardiovascular-Disease Risk Factors
by Andreassen, Ole A
American journal of human genetics, 2013-02-07, Vol.92 (2), p.197-209
12.
DTNBP1, NRG1, DAOA, DAO and GRM3 Polymorphisms and Schizophrenia: An Association Study
by Jönsson, Erik G
Neuropsychobiology, 2009-06, Vol.59 (3), p.142-150
13.
Dysbindin and D-Amino-Acid-Oxidase Gene Polymorphisms Associated with Positive and Negative Symptoms in Schizophrenia
by Wirgenes, Katrine V
Neuropsychobiology, 2009-09, Vol.60 (1), p.31-36
14.
Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis
by Beal, M. Flint
Nature medicine, 1999-03, Vol.5 (3), p.347-350
15.
Partitioning Heritability of Regulatory and Cell-Type-Specific Variants across 11 Common Diseases
by Trynka, Gosia
American journal of human genetics, 2014-11-06, Vol.95 (5), p.535-552
16.
Joint Analysis of Psychiatric Disorders Increases Accuracy of Risk Prediction for Schizophrenia, Bipolar Disorder, and Major Depressive Disorder
by Moser, Gerhard
American journal of human genetics, 2015-02-05, Vol.96 (2), p.283-294
17.
Estimation of Genetic Correlation via Linkage Disequilibrium Score Regression and Genomic Restricted Maximum Likelihood
by Moser, Gerhard
American journal of human genetics, 2018-06-07, Vol.102 (6), p.1185-1194
18.
Non-functional CYP2D6 alleles and risk for neuroleptic-induced movement disorders in schizophrenic patients
by ANDREASSEN, O. A
Psychopharmacologia, 1997, Vol.131 (2), p.174-179
19.
Oral dyskinesias and morphological changes in rat striatum during long-term haloperidol administration
by ANDREASSEN, Ole A
Psychopharmacologia, 2001, Vol.157 (1), p.11-19
20.
Correlation of vacuous chewing movements with morphological changes in rats following 1-year treatment with haloperidol
by MESHUL, C. K
Psychopharmacologia, 1996, Vol.125 (3), p.238-247
